Please find all related articles below.
In December 2014, the European Commission launched the latest public consultation on the review of the Working Time Directive 2003/88/EC in the hope to make progress following the failed negotiations of the cross-sectoral social partners at the end of 2012.
The Commission’s declared goal is to consider making appropriate changes that would make the Directive more suitable for dealing with the ongoing challenges Europe’s employment sectors are subject to. The outcomes of the (...)
In recent years, antimicrobial resistance (AMR) has been identified as a major health threat. The 2014 European Antibiotic Awareness Day drew attention to the consequences arising from the overuse and misuse of antibiotics, for instance through self-medication.
The emergence of multi-drug resistant ’superbugs’ as a result is a serious threat to health throughout Europe.
European Health Ministers recently issued Council conclusions which expand the EU level discourse about (...)
Since EU accession in 2007 Romania and Bulgaria have struggled to retain qualified health professionals. Doctors and nurses in particular have been leaving in significant numbers. Given the impacts of out-migration on health system sustainability and access to healthcare, the initiative taken by a regional hospital in Southern Romania has been highlighted by the Health Workers For All project as good practice in effective cross-border cooperation.
Long-term planning and the use of (...)
28 October 2014, Brussels – MEPs, patients and the European public health community are today asking President-elect Juncker to clarify whether medical devices and health technologies will remain in the directorate for health or not. Fears over patient safety remain as Mr Juncker has so far failed to publicly clarify his ambiguous statement (1) last week to the European Parliament.
Last week’s statement of the European Commission’s President-elect that the competence for (...)
Further to our Joint Letter of 16 September 2014 (1) , we are contacting you again to express our gratitude for your decision (2) to move the competence for medicines and pharmaceutical products back into the hands of the European Commissioner for Health. We firmly believe that this directorate is best placed to ensure a good balance between economic and public health objectives while promoting ‘smart, sustainable and inclusive’ growth for Europe.
28 October 2014, Brussels (...)
Brussels, 2 October 2014 - We are writing to support Member States who have already expressed their concerns on the decision of European Commission President Elect Jean-Claude Juncker to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of Internal Market and Industry within the new Commission. We would like to ask for your full support to have that decision reversed.
Dear Head of States, Dear Prime (...)
The fifth international influenza conference organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place in Riga on 14-17 September. A number of plenary and ’science/policy interface’ sessions examined the issue of low vaccination uptake in many Member States, as well as other issues related to pandemic preparedness and communication aspects of influenza-related health threats.
In the opening plenary, ’Why should influenza be a public (...)
More integrated prevention and care models have long been recognised as important elements in moving towards better quality and sustainability in healthcare, in particular in view of the rising burden of non-communicable diseases and demographic change, and the complexities of multiple morbidities that this brings.
By Sascha Marschang, EPHA Policy Manager for Health Systems and Milena Richter, Senior Director European Public Affairs, Sanofi.
While healthcare systems move towards (...)
22 July 2014 - Following in-depth discussions with members, EPHA responded to the European Commission’s public consultation on its Green Paper on mobile health (mHealth) in early July. In its response, EPHA emphasises that mHealth development should not only be seen as a way to gain cost efficiencies, but that relevant solutions - including smartphone applications - must first and foremost aim to bring concrete benefits for different types of end users including patients and health (...)
Ageing and Older People
Health Rights and Patients
As a fundamental pillar of the social and welfare model that defines and strengthens European identity, a solid health workforce is a public resource that must be secured at the local, national and global levels. Therefore EPHA supports the HW4All initiative with its goal of reinforcing the ethical guidelines outlined in the 2010 WHO Global Code of Practice on the International Recruitment of Health Personnel.
On 15 and 16 July, EPHA attended separate meetings with (...)